Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionInterleukin-4 (IL-4) receptor (CD124; IL-4RA) mAb
Molecular Target Interleukin-4 (IL-4) receptor (CD124) (IL-4RA)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationDermatitis
Indication DetailsTreat atopic dermatitis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today